NeoGenomics Inc (STU:NG9)
€ 12.6 -0.1 (-0.79%) Market Cap: 1.76 Bil Enterprise Value: 1.96 Bil PE Ratio: 0 PB Ratio: 1.97 GF Score: 76/100

Neogenomics Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 01:15AM GMT
Release Date Price: €14.5 (+0.69%)
Zach Conte JPMorgan Chase;Co.;Analyst

&-

Okay. If we could just sit down. We're going to start right now. I'm going to stand, but there you go. Yeah.

Hello, everyone. Thank you for coming. My name's Zach Conte, I'm a member of the healthcare investment banking team at JPMorgan. It's my pleasure to introduce you to NeoGenomics. Today, here we have Chris Smith, CEO; we've got Jeff Sherman, CFO; Vishal Sikri, President of Advanced Diagnostics; Warren Stone, President of Clinical. And I'll hand it off.

Chris Smith NeoGenomics
Inc. - CEO

Thanks, Zach. And for all of you, loyal investors, I appreciate you being here considering it's 7:00 AM and nothing in Michigan over Washington in the first quarter. I actually asked, could I put a slide in. Yeah, it really is a score. I hope I didn't blow it if you're not recording it, but I know it's been a long day. So appreciate you being here.

We're going to give you an update on the business and state of the business. I will say from a financial perspective, we haven't changed our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot